Diversification of edaravone via palladium-catalyzed hydrazine cross-coupling: Applications against protein misfolding and oligomerization of beta-amyloid
摘要:
N-Aryl derivatives of edaravone were identified as potentially effective small molecule inhibitors of tau and beta-amyloid aggregation in the context of developing disease-modifying therapeutics for Alzheimer's disease (AD). Palladium-catalyzed hydrazine monoarylation protocols were then employed as an expedient means of preparing a focused library of 21 edaravone derivatives featuring varied N-aryl substitution, thereby enabling structure-activity relationship (SAR) studies. On the basis of data obtained from two functional biochemical assays examining the effect of edaravone derivatives on both fibril and oligomer formation, it was determined that derivatives featuring an N-biaryl motif were four-fold more potent than edaravone. (C) 2015 Elsevier Ltd. All rights reserved.
Efficient palladium-catalyzed synthesis of substituted indoles employing a new (silanyloxyphenyl)phosphine ligand
作者:Christopher B. Lavery、Robert McDonald、Mark Stradiotto
DOI:10.1039/c2cc33071g
日期:——
The new and easily prepared OTips-DalPhos ligand (L1) offers broad substrate scope at relatively low loadings in the palladium-catalyzed C-N cross-coupling/cyclization of o-alkynylhalo(hetero)arenes with primary amines, affording indoles and related heterocyclic derivatives in high yield.
[EN] SILANYLOXYARYL PHOSPHINE LIGAND AND USES THEREOF IN C-N CROSS-COUPLING<br/>[FR] LIGAND À LA SILANYLOXYARYLE PHOSPHINE ET SES UTILISATIONS DANS LE COUPLAGE CROISÉ C-N
申请人:UNIV DALHOUSIE
公开号:WO2013159229A1
公开(公告)日:2013-10-31
The present invention pertains to silanyloxyaryl phosphine ligands of formula (I) and their uses with transition metal catalyst precursors for organic synthesis reactions. More particularly, the present invention pertains to the use of silanyloxyaryl phosphine ligands and with transition metal catalyst precursors in C-N cross-coupling reactions.
One-Pot Approach to 1,2-Disubstituted Indoles via Cu(II)-Catalyzed Coupling/Cyclization under Aerobic Conditions and Its Application for the Synthesis of Polycyclic Indoles
derivatives were efficiently and facilely synthesized from 2-alkynylanilines and boronic acids. 2-(2-Bromoaryl)-1-aryl-1H-indoles, which were selectively generated in one pot under the Cu catalysis, afforded the indolo[1,2-f]phenanthridines via Pd-catalyzed intramolecular direct C(sp2)–H arylation. The one-pot tandem approaches to the polycyclic indole derivatives were also successfully achieved.
通过Cu(II)催化的多米诺骨牌偶联/环化工艺已经开发出一种简单的1,2-二取代的吲哚组装体。在有氧条件下,可以从2-炔基苯胺和硼酸有效地合成各种1,2-二取代的吲哚衍生物。在铜催化下在一锅中选择性生成的2-(2-溴芳基)-1-芳基-1 H-吲哚通过Pd催化的分子内直接C(sp 2)提供吲哚[1,2- f ]菲啶)–芳基化。一锅串联方法也成功地实现了多环吲哚衍生物。
“On-Water,” Microwave-Assisted, Pd-Catalyzed Synthesis of Indoles from Imines and o-Difunctionalized Arenes
Regioselectively substituted indoles are prepared by a Pd‐catalyzed CC/CN bond‐forming sequence fromimines and o‐dihaloarenes or o‐haloarene sulfonates. The heterogeneous reaction as a suspension in water and under microwave heating offers important advantages in comparison with the conventional reaction in an organic solvent, among them, operational simplicity, the employment of KOH solutions instead
区域选择性取代的吲哚通过Pd催化的C中制备 C / C N键形成序列从亚胺和ö -dihaloarenes或ö -haloarene磺酸盐。与在有机溶剂中的常规反应相比,在水中和微波加热下作为悬浮液的非均相反应具有重要的优势,其中包括操作简便,使用KOH溶液代替醇盐以及显着减少反应时间。
CNT-CuO catalyzed C–N bond formation for N-arylation of 2-phenylindoles
作者:Jeongah Lim、Ji Dang Kim、Hyun Chul Choi、Sunwoo Lee
DOI:10.1016/j.jorganchem.2019.120970
日期:2019.12
Carbon nanotube-copper oxide (CNT-CuO) nanocomposites were prepared by depositing CuO nanoparticles onto functionalized CNT surfaces. The structure and elemental content of CNT-CuO were characterized using transmission electron microscopy, X-ray diffraction, and Auger electron spectroscopy. The prepared CNT-CuO was subsequently employed as a catalyst for the coupling reaction of 2-phenylindole with aryl iodides to provide the desired N-aryl 2-phenylindoles in good yields. (C) 2019 Published by Elsevier B.V.